NASDAQ
Lipocine Inc. (LPCN)
♥ 523 Thanks from members
Lipocine Inc. ($LPCN) presents a data-contested special situation following a Phase 3 trial miss for LPCN 1154 in postpartum depression, balanced by extended cash runway to August 2027 and ongoing TLANDO commercial royalties.